NCT01380353View on ClinicalTrials.gov

Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 12, 2012

Study Completion Date

November 12, 2012

Conditions
Breast Cancer
Interventions
DRUG

Diclofenac epolamine patch

Patch (10cm X 14cm) is comprised of an adhesive material containing 1.3% diclofenac epolamine which is applied to a non-woven polyester felt backing and covered with a polypropylene film release liner \[B\].

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT01380353 - Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine | Biotech Hunter | Biotech Hunter